Skip to content
Screener

Dermata Therapeutics, Inc. DRMA Q2 2026 earnings

Reported August 11, 2026 · After market close

EPS-$0.74Miss by $0.19
EPS estimate-$0.55

Next report

Nov 18, 2026 (in 3 months)
Revenue estimate$25.0K
EPS estimate-$0.55

FAQ

When did Dermata Therapeutics, Inc. report Q2 2026 earnings?
Dermata Therapeutics, Inc. (DRMA) reported Q2 2026 earnings on August 11, 2026 after market close.
What were Dermata Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Dermata Therapeutics, Inc. reported eps of $-0.74 for Q2 2026.
Did Dermata Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.55 by $0.19.
How did Dermata Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 55.4% from $-1.66.
Where can I find Dermata Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037124) and the 10-Q periodic report (0001493152-26-037127) directly on SEC EDGAR. The filing index links above go to sec.gov.